The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
..........will launch new products in due course according .............
When will be the due course. It is nearly 7years since they signed the agreement and still getting the cr*p in due course. Hope not it an illusive product. Time has come for IF to give them a kick.
Thanks gixer. I like the following paragraph. So what is this patented strain LPB27?
Previously, BY-HEALTH has successively released the research results of PCC1, the world's leading anti-aging substance, the first large-scale study on NAD+ and aging in Chinese population, and the research results of Qingluosu on improving blood flow health in Chinese population. Functions and new technologies, including the patented strain LPB27, which has been independently developed for 7 years, have been implemented on the product side.
Well well well. So much information about BH. Very good for BH share holders. What is happening to PXS share holder? It is keep on going down. Our good friend IF is happily drawing his handsome salary and being share holders we are just suc@@@@ our thumbs and watching the sp keep on sliding. Come on IF do something and update what is happening with our beloved FF.
gixer,
I have a very simple question. Who will produce FF in future when DSM's current stock finish. If it is DSM's machinery then they will mark a price to produce it. I do not think PXS has the ability to produce FF. Another option is BH will produce FF under the license of PXS. May be IF need to update what is in his mind about the future direction!!!